Patent pending technology developed by Spiriplex in
collaboration with the leading microarray scientists makes it all possible from a single drop of dried blood

All patient samples are run in triplicate with positive and negative controls in each well for unsurpassed
quality and accuracy.

37 allergen profile delivers superior positive predictive value to clinicians.
Direct comparisons ImmunoCAP™ and Siemens 3g demonstrate agreement in sensitivity, specificity and
detection levels.

Array technology eliminates the possibility of well to well variability that can be associated with
ELISA systems.